GLUT-1+/TKTL1+ coexpression predicts poor outcome in oral squamous cell carcinoma

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 117, Issue 6, 2014, Pages 743-753

  Grimm, Martin ^a   Munz, Adelheid ^a   Teriete, Peter ^b   Nadtotschi, Tatjana ^a   Reinert, Siegmar ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; TRANSKETOLASE; TUMOR MARKER;

ADULT; CANCER GRADING; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSKETOLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84901333418     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2014.02.007     Document Type: Article

References (50)

1. M. Grimm Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC Clin Transl Oncol 14 2012 870 880
2. M. Perez-Sayans, J.M. Suarez-Penaranda, G.D. Pilar, F. Barros-Angueira, J.M. Gandara-Rey, and A. Garcia-Garcia Hypoxia-inducible factors in OSCC Cancer Lett 313 2011 1 8
3. O. Warburg, K. Posener, and E. Negelein Über den Stoffwechsel der Carcinomzelle Biochem Z 1924 309 344
4. J.F. Coy, D. Dressler, J. Wilde, and P. Schubert Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer Clin Lab 51 2005 257 273
5. S. Langbein, M. Zerilli, and A. Zur Hausen et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted Br J Cancer 94 2006 578 585
6. H.U. Volker, C. Hagemann, and J. Coy et al. Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas Am J Clin Pathol 130 2008 50 57
7. M. Zerilli, M.C. Amato, and A. Martorana et al. Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases Cancer 113 2008 936 944
8. D. Hartmannsberger, B. Mack, and C. Eggert et al. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro Cancer Lett 300 2010 20 29
9. X. Xu, A. Zur Hausen, J.F. Coy, and M. Lochelt Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells Int J Cancer 124 2009 1330 1337
10. W. Sun, Y. Liu, and C.A. Glazer et al. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization Clin Cancer Res 16 2010 857 866
11. S. Zhang, J.H. Yang, C.K. Guo, and P.C. Cai Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells Cancer Lett 253 2007 108 114
12. M. Schmidt, H.U. Voelker, M. Kapp, M. Krockenberger, J. Dietl, and U. Kammerer Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK J Cancer Res Clin Oncol 136 2010 219 225
13. W. Yuan, S. Wu, and J. Guo et al. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo Cancer Biol Ther 9 2010 710 716
14. G. Kayser, W. Sienel, and B. Kubitz et al. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression Pathology 43 2011 719 724
15. J. Schwaab, K. Horisberger, and P. Strobel et al. Expression of transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy BMC Cancer 11 2011 363
16. S. Diaz-Moralli, M. Tarrado-Castellarnau, C. Alenda, A. Castells, and M. Cascante Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation PLoS One 6 2011 e25323
17. C. Wanka, J.P. Steinbach, and J. Rieger Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis J Biol Chem 287 2012 33436 33446
18. M. Grimm, S. Schmitt, and P. Teriete et al. A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells BMC Cancer 13 2013 569
19. M. Grimm, T. Henopp, and S. Hoefert et al. Multiple osteolytic lesions of intraosseous adenoid cystic carcinoma in the mandible mimicking apical periodontitis Int Endod J 45 2012 1156 1164
20. G. Semenza Signal transduction to hypoxia-inducible factor 1 Biochem Pharmacol 64 2002 993 998
21. M. Kunkel, T.E. Reichert, and P. Benz et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma Cancer 97 2003 1015 1024
22. M. Kunkel, M. Moergel, and M. Stockinger et al. Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity Oral Oncol 43 2007 796 803
23. S. Ohba, H. Fujii, and S. Ito et al. Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis J Oral Pathol Med 39 2010 74 78
24. A.W. Eckert, M.H. Lautner, and A. Schutze et al. Co-expression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients J Oral Pathol Med 39 2010 313 317
25. M. Tian, H. Zhang, Y. Nakasone, K. Mogi, and K. Endo Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study Eur J Nucl Med Mol Imaging 31 2004 5 12
26. Y. Kondo, K. Yoshikawa, and Y. Omura et al. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma Oncol Rep 25 2011 1227 1233
27. F.R. Ayala, R.M. Rocha, and K.C. Carvalho et al. GLUT1 and GLUT3 as potential prognostic markers for oral squamous cell carcinoma Molecules 15 2010 2374 2387
28. A.W. Eckert, M.H. Lautner, H. Taubert, J. Schubert, and U. Bilkenroth Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients Oncol Rep 20 2008 1381 1385
29. T. Yamada, M. Uchida, and K. Kwang-Lee et al. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas Oral Surg Oral Med Oral Pathol Oral Radiol 113 2012 464 471
30. M. Shimanishi, K. Ogi, and Y. Sogabe et al. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia J Oral Pathol Med 42 2013 382 388
31. R.E. Airley, and A. Mobasheri Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics Chemotherapy 53 2007 233 256
32. A.W. Eckert, M. Kappler, J. Schubert, and H. Taubert Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients Oral Maxillofac Surg 16 2012 189 196
33. L.H. Sobin, C. Wittekind, and M.K. Gospodarowicz Union for International Cancer Control. TNM Classification of Malignant Tumours 7th ed 2010 Wiley-Blackwell
34. S.R. Hamilton, and L.A. Aaltonen World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System 3rd ed. 2000 IARC Press Lyon, France
35. B.H. von Rahden, S. Kircher, and M. Kafka et al. Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa Cancer Biomark 7 2010 285 294
36. R.A. Walker Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment I Histopathology 49 2006 406 410
37. V.J. Tuominen, T.T. Tolonen, and J. Isola ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry Histopathology 60 2012 758 767
38. K.G. Edington, O.P. Loughran, I.J. Berry, and E.K. Parkinson Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss Mol Carcinog 13 1995 254 265
39. D. Alexander, F. Schafer, and M. Olbrich et al. MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity Cell Physiol Biochem 26 2010 1073 1080
40. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 75 1958 457 487
41. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
42. D.R. Cox Regression models and life tables J R Stat Soc 34 1972 1987 2001
43. R.A. Dierckx, and C. Van de Wiele FDG uptake, a surrogate of tumour hypoxia? Eur J Nucl Med Mol Imaging 35 2008 1544 1549
44. M.W. Han, H.J. Lee, and K.J. Cho et al. Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer Head Neck 34 2012 1395 1402
45. S.J. Li, W. Guo, G.X. Ren, G. Huang, T. Chen, and S.L. Song Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography Br J Oral Maxillofac Surg 46 2008 180 186
46. O. Feyen, J.F. Coy, V. Prasad, R. Schierl, J. Saenger, and R.P. Baum EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignancies Future Oncol 8 2012 1349 1359
47. D.A. Tennant, R.V. Duran, and E. Gottlieb Targeting metabolic transformation for cancer therapy Nat Rev Cancer 10 2010 267 277
48. B.G. Allen, S.K. Bhatia, and J.M. Buatti et al. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts Clin Cancer Res 19 2013 3905 3913
49. A. Paoli, A. Rubini, J.S. Volek, and K.A. Grimaldi Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets Eur J Clin Nutr 67 2013 789 796
50. M.G. Abdelwahab, K.E. Fenton, and M.C. Preul et al. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma PLoS One 7 2012 e36197